486 related articles for article (PubMed ID: 28314744)
21. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
Nagano C; Sako M; Kamei K; Ishikura K; Nakamura H; Nakanishi K; Omori T; Nozu K; Iijima K
BMC Nephrol; 2019 Aug; 20(1):293. PubMed ID: 31375087
[TBL] [Abstract][Full Text] [Related]
22. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
Kemper MJ; Valentin L; van Husen M
Pediatr Nephrol; 2018 Oct; 33(10):1641-1649. PubMed ID: 28879428
[TBL] [Abstract][Full Text] [Related]
23. Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome.
Iorember F; Aviles D; Kallash M; Bamgbola O
Pediatr Nephrol; 2018 Feb; 33(2):261-267. PubMed ID: 28864927
[TBL] [Abstract][Full Text] [Related]
24. Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome.
Liu J; Shen Q; Xie L; Wang J; Li Y; Chen J; Fang X; Tang X; Qian B; Xu H
BMJ Open; 2022 Oct; 12(10):e064216. PubMed ID: 36223961
[TBL] [Abstract][Full Text] [Related]
25. Rituximab efficiency in children with steroid-dependent nephrotic syndrome.
Sellier-Leclerc AL; Macher MA; Loirat C; Guérin V; Watier H; Peuchmaur M; Baudouin V; Deschênes G
Pediatr Nephrol; 2010 Jun; 25(6):1109-15. PubMed ID: 20238230
[TBL] [Abstract][Full Text] [Related]
26. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
Basu B; Mahapatra TK; Mondal N
Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
[TBL] [Abstract][Full Text] [Related]
27. Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled study.
Ravani P; Lugani F; Pisani I; Bodria M; Piaggio G; Bartolomeo D; Prunotto M; Ghiggeri GM
Pediatr Nephrol; 2020 Aug; 35(8):1437-1444. PubMed ID: 32232637
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K; Ogura M; Sato M; Sako M; Iijima K; Ito S
Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
[TBL] [Abstract][Full Text] [Related]
29. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.
Iijima K; Sako M; Kamei K; Nozu K
Pediatr Nephrol; 2018 Sep; 33(9):1449-1455. PubMed ID: 28717938
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K;
Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242
[TBL] [Abstract][Full Text] [Related]
31. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.
Taşdemir M; Canpolat N; Yıldız N; Özçelik G; Benzer M; Saygılı SK; Özkayin EN; Türkkan ÖN; Balat A; Candan C; Çelakıl M; Yavuz S; Akıncı N; Göknar N; Akgün C; Tülpar S; Alpay H; Sever FL; Bilge İ
Turk J Med Sci; 2021 Aug; 51(4):1781-1790. PubMed ID: 33581711
[TBL] [Abstract][Full Text] [Related]
32. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F
Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150
[TBL] [Abstract][Full Text] [Related]
33. Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy.
Ramachandran R; Bharati J; Rao I; Kashif AW; Nada R; Minz R; Gupta KL; Kohli HS
Nephrology (Carlton); 2019 Dec; 24(12):1241-1247. PubMed ID: 30586217
[TBL] [Abstract][Full Text] [Related]
34. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
35. Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Podestà MA; Trillini M; Portalupi V; Gennarini A; Tomatis F; Villa A; Perna A; Rubis N; Remuzzi G; Ruggenenti P
Am J Kidney Dis; 2024 Mar; 83(3):340-349.e1. PubMed ID: 37777061
[TBL] [Abstract][Full Text] [Related]
36. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil
Ehren R; Benz MR; Doetsch J; Fichtner A; Gellermann J; Haffner D; Höcker B; Hoyer PF; Kästner B; Kemper MJ; Konrad M; Luntz S; Querfeld U; Sander A; Toenshoff B; Weber LT;
BMJ Open; 2018 Oct; 8(10):e024882. PubMed ID: 30309995
[TBL] [Abstract][Full Text] [Related]
37. Rituximab for nephrotic syndrome in children.
Iijima K; Sako M; Nozu K
Clin Exp Nephrol; 2017 Apr; 21(2):193-202. PubMed ID: 27422620
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
[TBL] [Abstract][Full Text] [Related]
39. Rituximab in maintaining remission in adults with podocytopathy.
Ramachandran R; Bharati J; Nada R; Minz R; Kohli HS
Nephrology (Carlton); 2020 Aug; 25(8):616-624. PubMed ID: 32297386
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial.
Basu B; Sander A; Roy B; Preussler S; Barua S; Mahapatra TKS; Schaefer F
JAMA Pediatr; 2018 Aug; 172(8):757-764. PubMed ID: 29913001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
